What are Pelthos Therapeutics Inc.'s profit margins?

Pelthos Therapeutics Inc. (PTHS) runs a 79.6% gross margin and a -157.7% operating margin, with a -186.2% net margin.

Where do Pelthos Therapeutics Inc.'s ratios come from?

Every ratio is computed from Pelthos Therapeutics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Pelthos Therapeutics Inc. PTHS Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on assets	-70.5%-4.8pp	-65.8%-29.1pp	-36.7%—	——	——
Efficiency
Asset turnover	0.4×+0.1×	0.3×+0.1×	0.1×—	——	——
Liquidity
Current ratio	2.8×+0.7×	2.1×0.0×	2×+1.9×	0.1×-0.1×	0.2×-0.2×
Quick ratio	1.9×+0.7×	1.1×+0.1×	1×+0.9×	0.1×-0.1×	0.2×-0.2×
Cash ratio	1.3×+0.6×	0.7×+0.1×	0.6×+0.6×	0×0.0×	0×-0.1×
Leverage
Interest coverage	-8.4×—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Pelthos Therapeutics Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Pelthos Therapeutics Inc.'s profit margins?: Pelthos Therapeutics Inc. (PTHS) runs a 79.6% gross margin and a -157.7% operating margin, with a -186.2% net margin.
Where do Pelthos Therapeutics Inc.'s ratios come from?: Every ratio is computed from Pelthos Therapeutics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.